Head to head

MK-677 vs Ipamorelin

This one is a genuine fork, because the two are taken completely differently — a daily pill versus an injection — even though they nudge the same hormone.

The short answer. Both are growth-hormone secretagogues, but the practical split is route and duration: MK-677 (ibutamoren) is an oral, long-acting daily compound; ipamorelin is a short-acting injectable peptide. That difference drives how you'd schedule and log each.

Side by side

 MK-677Ipamorelin
ClassPeptidesPeptides
FormOralInjection
Half-life≈ 6 hours≈ 2 hours
StorageRoom temperature
Dose unitsmgmcg, mg
FDA statusNot FDA-approvedNot FDA-approved

Facts from the Stack compound library. See the full pages: MK-677 · Ipamorelin.

How they differ

Route

MK-677 is oral — no needles, no reconstitution. Ipamorelin is injectable and has to be mixed from powder. That alone changes the logging workflow.

Duration & cadence

MK-677's long half-life supports once-daily dosing; ipamorelin is short-acting. A daily oral and a short-acting injectable produce very different 'in your system' curves.

Tracking implications

For MK-677, consistency is the whole game — a daily check-off with a reminder. For ipamorelin, site and timing matter. Same app, different logging emphasis.

Status

Both are research compounds, not approved for human use. Labeled as such in the library.

Tracking either one

Whichever you log, the workflow is the same in Stack: add it once, set the schedule, and let the app handle reminders, supply projection and an "in your system" curve from the half-life. Run both? Group them into one protocol you can pause together.

Track your stack in Stack

Free, private, no account. Doses, schedules, supply and trends in one quiet app.

Get the app
Not medical advice. This page compares publicly-documented properties of two compounds for educational purposes. It does not recommend either one, or any dose. How we source →

Last reviewed 2026-06-11